Pantoprazol Hikma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Hikma, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and ulcers in adults.

GNH USA supplies Pantoprazol Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Hikma is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosive lesions and prevents further damage. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Pantoprazol Hikma may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: watery stools without blood. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild cramping. - Flatulence: increased intestinal gas. - Constipation: infrequent, hard stools.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with abdominal pain. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Liver enzyme elevation: asymptomatic rise in hepatic transaminases. - Fracture risk: increased incidence of hip, wrist or spine fractures with long‑term use.

When prescribing Pantoprazol Hikma, consider the following safety measures: - Assess renal function: adjust use in severe renal impairment. - Evaluate bone health: monitor patients at risk for fractures during prolonged therapy. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start with the lowest effective dose and monitor for adverse effects. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Pantoprazol Hikma can affect the pharmacokinetics of several medicines. Awareness of these interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption leading to treatment failure. - Atazanavir: markedly decreased antiviral levels, compromising HIV therapy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent coagulation monitoring. - Digoxin: slight rise in serum concentrations, may need dose adjustment. - Methotrexate: reduced clearance can increase toxicity, especially at high doses. - Iron supplements: decreased iron absorption, consider timing separation.